Half-year report · Q2
7459.TEDINET S100UQW8
Period2024-04-01 → 2024-09-30
Filed2024-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.82T | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥3.56T | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.78T | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Operating income | ¥27.2bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Operating income | ¥20.6bn | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Ordinary income | ¥35.1bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥64.6bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥29.3bn | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥39.8bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥32.8bn | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥21.7bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥41.5bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥17.2bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥27.6bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Net income | ¥22.5bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Total assets | ¥1.88T | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥1.80T | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥1.82T | at 2023-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.12T | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥1.06T | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥757.7bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥736.6bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥714.6bn | at 2023-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥251.1bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥230.2bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥249.0bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥228.1bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥207.0bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥193.6bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥41.8bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥61.8bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥31.2bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥6.5bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥7.8bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥10.8bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥14.4bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥25.2bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥12.7bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥103.94 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥195.83 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥80.48 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 32.9% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.4% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.1% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥2.0bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥2.0bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | ¥161m |
| jpcrp040300-q2r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥58.6bn |
| jpcrp040300-q2r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥58.6bn |
| jpcrp040300-q2r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥1m |
| jpcrp040300-q2r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥600.4bn |
| jpcrp040300-q2r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥600.2bn |
| jpcrp040300-q2r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥201m |
| jpcrp040300-q2r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥14.0bn |
| jpcrp040300-q2r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥1.17T |
| jpcrp040300-q2r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥1.17T |
| jpcrp040300-q2r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥1.8bn |
| jpcrp040300-q2r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥11.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥1.83T |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥1.82T |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥27.0bn |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥1.2bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥1.2bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥37m |
| jpcrp040300-q2r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥56.8bn |
| jpcrp040300-q2r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥56.8bn |
| jpcrp040300-q2r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥1m |
| jpcrp040300-q2r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale And Related Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥1.5bn |
| jpcrp040300-q2r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥583.4bn |
| jpcrp040300-q2r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥583.3bn |
| jpcrp040300-q2r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥146m |
| jpcrp040300-q2r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥13.8bn |
| jpcrp040300-q2r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥1.14T |
| jpcrp040300-q2r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥1.14T |
| jpcrp040300-q2r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥1.1bn |
| jpcrp040300-q2r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥5.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥1.78T |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥1.78T |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥1.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥20.7bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 513
| Item | Context | Value | Unit |
|---|---|---|---|
| Noncurrent liabilities | CurrentQuarterInstant | 59825000000 | JPY |
| Liabilities | Prior1YearInstant | 1062515000000 | JPY |
| Liabilities | CurrentQuarterInstant | 1122104000000 | JPY |
| Capital stock | Prior1YearInstant | 22398000000 | JPY |
| Capital stock | CurrentQuarterInstant | 22398000000 | JPY |
| Capital surplus | Prior1YearInstant | 99807000000 | JPY |
| Capital surplus | CurrentQuarterInstant | 99866000000 | JPY |
| Retained earnings | Prior1YearInstant | 439315000000 | JPY |
| Retained earnings | CurrentQuarterInstant | 450677000000 | JPY |
| Treasury stock | Prior1YearInstant | -21254000000 | JPY |
| Treasury stock | CurrentQuarterInstant | -22192000000 | JPY |
| Shareholders equity | Prior1YearInstant | 540265000000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 550750000000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 70347000000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 77231000000 | JPY |
| Deferred gains or losses on hedges | Prior1YearInstant | -3000000 | JPY |
| Deferred gains or losses on hedges | CurrentQuarterInstant | -32000000 | JPY |
| Revaluation reserve for land | Prior1YearInstant | -13415000000 | JPY |
| Revaluation reserve for land | CurrentQuarterInstant | -13415000000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 1908000000 | JPY |
| Foreign currency translation adjustment | CurrentQuarterInstant | 2791000000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 1246000000 | JPY |
| Remeasurements of defined benefit plans | CurrentQuarterInstant | 1114000000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 60083000000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 67689000000 | JPY |
| Subscription rights to shares | Prior1YearInstant | － | JPY |
| Subscription rights to shares | CurrentQuarterInstant | 1000000 | JPY |
| Non controlling interests | Prior1YearInstant | 136263000000 | JPY |
| Non controlling interests | CurrentQuarterInstant | 139213000000 | JPY |
| Net assets | Prior1YearInstant | 736612000000 | JPY |
| Net assets | CurrentQuarterInstant | 757655000000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 1799127000000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 1879759000000 | JPY |
| Net sales | Prior1YTDDuration | 1778989000000 | JPY |
| Net sales | CurrentYTDDuration | 1824672000000 | JPY |
| Cost of sales | Prior1YTDDuration | 1657614000000 | JPY |
| Cost of sales | CurrentYTDDuration | 1698231000000 | JPY |
| Gross profit | Prior1YTDDuration | 121375000000 | JPY |
| Gross profit | CurrentYTDDuration | 126441000000 | JPY |
| Salaries and allowances sga | Prior1YTDDuration | 35641000000 | JPY |
| Salaries and allowances sga | CurrentYTDDuration | 36918000000 | JPY |
| Welfare expenses sga | Prior1YTDDuration | 7002000000 | JPY |
| Welfare expenses sga | CurrentYTDDuration | 7413000000 | JPY |
| Provision for bonuses sga | Prior1YTDDuration | 7173000000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 7197000000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 1925000000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 1412000000 | JPY |
| Distribution expenses sga | Prior1YTDDuration | 9835000000 | JPY |
| Distribution expenses sga | CurrentYTDDuration | 11858000000 | JPY |
| Rents sga | Prior1YTDDuration | 2419000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |